Product Information
METOLAZONE 5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.2392 per EA under NDC 60687063501. Its NADAC has been published 239 times since Mar 9, 2022.
FDA first approved this application on Mar 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Metolazone market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
American Health PackagingNDC
60687063501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOLAZONEApproval Type
Generic (ANDA)
FDA Application
ANDA213827FDA Approved
3/30/2021
TE Code
AB
On Market Since
2/16/2022
Pharmacological Classes
Price Statistics
The NADAC for METOLAZONE 5 MG TABLET has been published 239 times since Mar 9, 2022, and over the history we have for it it has declined 63.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2392 per EA |
|---|---|
| All-time high | $0.8039 (Jan 11, 2023) |
| All-time low | $0.2163 (Apr 17, 2024) |
| 52-week high | $0.3323 |
| 52-week low | $0.2392 |
| Median price | $0.3176 |
| Average price | $0.3800 |
| Largest weekly change | -53.2% (Jan 18, 2023) |
| Weeks tracked | 239 |
| Tracking since | Mar 9, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metolazone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thiazide-like Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOLAZONE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METOLAZONE 5 MG TABLET, manufactured by American Health Packaging, is $0.2392 per EA (NDC 60687063501), effective Sep 30, 2026.
How has the price of METOLAZONE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METOLAZONE 5 MG TABLET has declined 63.5%. It has been tracked across 239 weekly CMS publications since Mar 9, 2022.
What are the highest and lowest recorded NADAC prices for METOLAZONE 5 MG TABLET?
Since Mar 9, 2022, the NADAC for METOLAZONE 5 MG TABLET has ranged from a low of $0.2163 (Apr 17, 2024) to a high of $0.8039 (Jan 11, 2023), with a median of $0.3176 per EA.
Are there cheaper alternatives to METOLAZONE 5 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOLAZONE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METOLAZONE 5 MG TABLET?
METOLAZONE 5 MG TABLET (NDC 60687063501) is labeled by American Health Packaging, and CMS classifies it as a generic product.